Filter
1619
Filtered Results: 1619
Text search:
Regional
Office
South-East
Asia,
World
Health
Organization
Featured
Recommendations
154
New Publications
433
Language
Document type
No document type
832
Studies & Reports
375
Guidelines
195
Manuals
81
Strategic & Response Plan
65
Training Material
20
Fact sheets
16
Situation Updates
15
Resource Platforms
11
Infographics
5
Brochures
2
Online Courses
2
Countries / Regions
Global
113
South–East Asia Region
72
India
64
Myanmar / Burma
62
Nepal
45
Asia
43
Bangladesh
31
Philippines
28
Western and Central Europe
28
Indonesia
22
Africa
21
Cambodia
19
Uganda
16
Ethiopia
15
Western Pacific Region
14
Thailand
13
Kenya
13
Syria
13
Tanzania
13
Middle East and North Africa
11
South Africa
11
Liberia
11
Eastern Europe
10
Pakistan
10
Zambia
9
Ukraine
8
Ghana
8
Afghanistan
8
Rwanda
7
Nigeria
7
Haiti
7
Latin America and the Carribbean
7
Yemen
7
Laos
6
Malawi
6
Mozambique
6
Congo, Democratic Republic of
6
West and Central Africa
6
Sri Lanka
6
Sierra Leone
5
China
5
Senegal
5
Eastern Europe and Central Asia
5
East and Southern Africa
5
Russia
5
Sudan
5
South Sudan
5
Zimbabwe
4
Venezuela
4
Vietnam
4
Moldova
4
Somalia
4
North Macedonia
3
Timor Leste/ East Timor
3
Turkey
3
Burkina Faso
3
Jordan
3
Georgia
3
Central African Republic
3
Mexico
2
Kazakhstan
2
Iran
2
Albania
2
Malaysia
2
Guinea
2
USA
2
Belarus
2
Bosnia and Herzegovina
2
Lebanon
2
Papua New Guinea
2
Eswatini/ Swaziland
2
Tajikistan
1
North Korea
1
Lesotho
1
Cameroon
1
Singapore
1
Kyrgyzstan
1
Peru
1
Morocco
1
Mongolia
1
Qatar
1
Armenia
1
Croatia
1
Hungary
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Tunisia
1
Argentina
1
Brazil
1
Djibouti
1
Namibia
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Poland
1
Mali
1
Bhutan
1
Botswana
1
Iraq
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
392
Clinical Guidelines
184
Public Health
125
Key Resources
120
Women & Child Health
118
Capacity Building
35
Pharmacy & Technologies
20
Toolboxes
HIV
161
Mental Health
130
COVID-19
109
Planetary Health
101
TB
79
NTDs
71
Rapid Response
68
AMR
58
Global Health Education
53
Disability
52
Caregiver
42
Refugee
39
NCDs
33
Natural Hazards
31
Health Financing Toolbox
29
Conflict
27
Pharmacy
18
Zika
18
Ebola & Marburg
12
Polio
10
Cholera
9
Specific Hazards
7
Malaria
5
Typhoon
3
Social Ethics
1
A review of proactive risk assessment and risk management practices to ensure the safety of drinking-water
Based on information gathered from 118 countries representing every region of the globe, this report provides a picture of WSP uptake worldwide. It presents information on WSP implementati...
Based on information gathered from 118 countries representing every region of the globe, this report provides a picture of WSP uptake worldwide. It presents information on WSP implementati...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
Safe drinking-water management must consider drinking-water quality, acceptability and quantity in the context of public health protection. In this manual, the term “safety” encompasses these three elements. Although the principles in this manual can be broadly applied to all types of drinking-w...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
WHO has issued a new recommendation on the length of bladder catheterization following surgical repair of a simple obstetric urinary fistula. Currently the length of catheterization is not standard and ranges from 5 to 42 days. The new guidance recommends a 7–10 day period of bladder catheterizati...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
Training for staff working at DR-TB management centres.
Training modules
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio...
